Variability in the evaluation and management of opiate-exposed newborns in Maryland

Clinical Pediatrics

Volumn 46, Issue 7, 2007, Pages 632-635

  Crocetti, Michael T ^a,b   Amin, Diane D ^a   Jansson, Lauren M ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Methadone; Neonatal abstinence syndrome; Newborn; Opiates; Protocol

Indexed keywords

OPIATE;

ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DELIVERY; EVALUATION; HEALTH SURVEY; HOSPITAL PERSONNEL; HUMAN; LENGTH OF STAY; NEWBORN; NEWBORN CARE; NEWBORN SCREENING; PRACTICE GUIDELINE; PRENATAL EXPOSURE; UNITED STATES;

ADOLESCENT; ADULT; DATA COLLECTION; FEMALE; HUMANS; INFANT, NEWBORN; MARYLAND; METHADONE; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PRACTICE GUIDELINES; PREGNANCY;

EID: 34547573650     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922807300699     Document Type: Article

References (18)

1. The National Survey on Drug Use and Health. Substance use during pregnancy: 2002 and 2003 update. Substance Abuse and Mental Health Services Administration ;. 2005. Available at: http://www.drugabusestatistics.samhsa.gov/ nsduh.htm. Accessed May 15, 2006.
2. Jones HE, Johnson RE, Jasinski DR, et al. Buprenorphine versus methadone in the treatment of pregnant opioiddependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005 ; 79: 1-10.
3. American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics. 1998 ;101: 1079-1088.
4. Kandall SR, Albin RS, Gartner LM, Lee KS, Eidelman A. The narcotic dependent mother: fetal and neonatal consequences. Early Hum Dev. 1977 ; 1: 159-169.
5. Rajegowda BK, Glass L., Evans H., Maso G., Swartz DP, Leblanc W. Methadone withdrawal in newborn infants. J Pediatr. 1972 ; 81: 532-534.
6. Wilson GS, Desmond MM, Wait RB Follow-up of methadone treated and untreated narcotic dependent women and their infants: health, development, and social implications. J Pediatr. 1981 ; 98: 716-722.
7. Kaltenbach K., Finnegan LP Neonatal abstinence syndrome, pharmacotherapy, and developmental outcome. Neurobehav Toxicol Teratol. 1986 ; 8: 353-355.
8. Fabris C., Prandi G., Perathoner C., Soldi A. Neonatal drug addiction. Panminerva Med. 1998 ; 40: 239-243.
9. Elliot MR, Cunliffe P., Demianczuk N., Robertson CM Frequency of newborn behaviours associated with neonatal abstinence syndrome: a hospital-based study. J Obstet Gynaecol Can. 2004 ; 26: 25-34.
10. Jansson LM, Velez M. Understanding and treating substance abusers and their infant. Infants Young Child. 1999 ; 11: 79-89.
11. Connaughton JF, Reeser D., Schut J., Finnegan LP Perinatal addiction: outcome and management. Am J Obstet Gynecol. 1977 ; 129: 679-686.
12. Finnegan LP, Kron RE, Connaughton JF, Emich JP Neonatal Abstinence Syndrome: Assessment and management. Addict Dis. 1975 ; 2 ; 141-158.
13. Finnegan LP, Kron RE, Connaughton JF, Emich JP Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm. 1975 ; 12: 19-32.
14. Lipsitz PJ A proposed narcotic withdrawal score for use with newborn infants: a pragmatic evaluation of its efficacy. Clin Pediatr. 1975 ; 14: 592-594.
15. Ostrea EM, Chavez CJ, Strauss ME A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr. 1976 ; 88: 642-645.
16. Jackson L., Ting A., McKay S., Galea P., Skoech C. A randomized controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed. 2004 ; 89: F300 - F304.
17. Chapman JP, Galea P. Neonatal abstinence syndrome at Glasgow Royal maternity hospital. Health Bull. 1999 ; 57: 247-251.
18. Sarker S., Donn SM Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol. 2006 ; 26: 15-17.